Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 CAD | 0.00% | +100.00% | 0.00% |
02-29 | Braxia Scientific Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
2023 | Braxia Scientific Corp. Announces Board Changes | CI |
Sales 2022 | 1.49 2.03 118.4 | Sales 2023 | 1.88 2.57 150.01 | Capitalization | 6.59M 9M 525M |
---|---|---|---|---|---|
Net income 2022 | -12M -16.38M -955M | Net income 2023 | -13M -17.74M -1.03B | EV / Sales 2022 | 2,322,657 x |
Net cash position 2022 | 8.46M 11.55M 674M | Net cash position 2023 | 1.26M 1.71M 99.93M | EV / Sales 2023 | 2,832,851 x |
P/E ratio 2022 |
-0.87
x | P/E ratio 2023 |
-0.43
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 56.58% |
1 week | +100.00% | ||
Current month | +100.00% | ||
3 months | +100.00% | ||
6 months | -33.33% |
Managers | Title | Age | Since |
---|---|---|---|
Roger McIntyre
CEO | Chief Executive Officer | - | 10/05/20 |
Peter Rizakos
DFI | Director of Finance/CFO | - | 07/01/21 |
Jason Wolkove
CTO | Chief Tech/Sci/R&D Officer | - | 03/07/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jerry Habuda
BRD | Director/Board Member | 67 | 18/08/19 |
Roger McIntyre
CEO | Chief Executive Officer | - | 10/05/20 |
Olga Cwiek
BRD | Director/Board Member | - | 31/01/21 |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 0.01 | 0.00% | 1 000 |
25/04/24 | 0.01 | +100.00% | 20,510 |
24/04/24 | 0.005 | 0.00% | 51,000 |
23/04/24 | 0.005 | 0.00% | 68,000 |
22/04/24 | 0.005 | 0.00% | 6,109 |
Delayed Quote Canadian Securities Exchange, April 29, 2024 at 02:30 pm
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 2.07M | |
-14.34% | 84.68B | |
+14.80% | 81.12B | |
+11.62% | 29.59B | |
-8.78% | 16.73B | |
-1.39% | 16.36B | |
-31.58% | 11.77B | |
+1.82% | 11.72B | |
+30.84% | 11.71B | |
-0.47% | 11.66B |
- Stock Market
- Equities
- BRAX Stock